Ambulatory abdominal inductance plethysmography (AIP): Towards objective assessment of abdominal distension in irritable bowel syndrome

Objective. To explore the efficacy of Herb-partitioned moxibustion in treating IBS-D patients.Method. 210 IBS-D patients were randomly assigned on a3:3:2basis to group HM, group FM, or group PB for 4-week treatment. The change of GSRS total score at weeks 4 and 8, the changes of GSRS specific scores, and adverse events were evaluated.Results. Patients in group HM and group FM had lower GSRS total score at week 4 (1.98±0.303,2.93±0.302versus3.73±0.449) and at week 8 (2.75±0.306,3.56±0.329versus4.39±2.48) as compared with patients’ score in group PB. However, there was no significant difference of GSRS total score between group HM and group FM. The effect of HM was significantly greater than that of orally taking PB in ameliorating the symptoms of rugitus (0.38 versus 0.59,P<0.05), abdominal pain (0.28 versus 0.57,P<0.01), abdominal distension (0.4 versus 0.7,P<0.01), and increased passage of stools (0.06 versus 0.25,P<0.01) at the end of treatment period. In the follow-up period, patients’ therapeutic effect in group HM remained greater than that in group FM (in abdominal pain, abdominal distension, and increased passage of stools) and that in group PB (in loose stools).Conclusions. HM appears to be a promising, efficacious, and well-tolerated treatment for patients with IBS-D.

Download Full-text

Abdominal distension in irritable bowel syndrome (IBS): Is there a relationship to visceral sensitivity?

Gastroenterology ◽

10.1016/s0016-5085(03)82012-7 ◽

2003 ◽

Vol 124 (4) ◽

pp. A398 ◽

Cited By ~ 1

Author(s):

Richard Lea ◽

Lesley A. Houghton ◽

Brian Reilly ◽

Peter J. Whorwell

Keyword(s):

Irritable Bowel Syndrome ◽

Abdominal Distension ◽

Visceral Sensitivity ◽

Irritable Bowel

Download Full-text

Abdominal distension in health and irritable bowel syndrome: The effect of bladder filling

Neurogastroenterology & Motility ◽

10.1111/nmo.13437 ◽

2018 ◽

Vol 30 (11) ◽

pp. e13437

Author(s):

Basma Issa ◽

Julie Morris ◽

Peter J Whorwell

Keyword(s):

Irritable Bowel Syndrome ◽

Abdominal Distension ◽

Bladder Filling ◽

Irritable Bowel

Download Full-text

EVALUATION OF CARBOHYDRATE AND FIBER CONSUMPTION IN PATIENTS WITH IRRITABLE BOWEL SYNDROME IN OUTPATIENT TREATMENT

Arquivos de Gastroenterologia ◽

10.1590/s0004-2803.201900000-12 ◽

2019 ◽

Vol 56 (1) ◽

pp. 3-9 ◽

Cited By ~ 2

Author(s):

Suzana Soares LOPES ◽

Sender Jankiel MISZPUTEN ◽

Anita SACHS ◽

Maria Martha LIMA ◽

Orlando AMBROGINI JR

Keyword(s):

Irritable Bowel Syndrome ◽

Abdominal Distension ◽

Functional Condition ◽

Carbohydrate Intake ◽

Sample Population ◽

Mixed Group ◽

Food Groups ◽

Fiber Consumption ◽

Fermentable Carbohydrates ◽

Irritable Bowel

ABSTRACT BACKGROUND: Irritable bowel syndrome (IBS) is a chronic functional condition, which main symptoms of pain, discomfort and abdominal distension, constipation, diarrhea, altered fecal consistency and sensation of incomplete evacuation can be influenced by the presence of dietary fiber and fermentable carbohydrates (FODMAPs). This study aimed to assess the relationship between the quantity of fermentable carbohydrates (FODMAP) and fiber consumed by individuals diagnosed with IBS, and their classification according to the Rome III criteria. METHODS: A transversal study was carried out in the Intestinal Outpatient Clinic of the Gastroenterology Discipline of UNIFESP. The nutrients of interest for the study were: fiber, general carbohydrates and FODMAPs, with intake quantity measured in grams, analyzed through portions consumed. A nutrition log was used, along with a semi-quantitative questionnaire of consumption frequency. RESULTS: The sample included 63 adult patients; 21 with constipated IBS, 21 with diarrhea IBS, and 21 with mixed IBS. Carbohydrate intake was suboptimal in 55.6% of patients in all groups; excessive consumption was identified in 38.1% of the diarrhea group, 14.3% of the mixed group and 38.1% of the constipated group. Low consumption of carbohydrates was found in 28.6% of diarrhea patients and 47.6% of the mixed group. A mean intake of 23 g of fiber per day was identified, lower than recommended. CONCLUSION: The study identified a number of inadequacies in the consumption of different nutrients, excessive carbohydrate intake, especially FODMAPs, identified by the respondents as responsible for a worsening of their conditions. By contrast, other food groups such as meat, eggs and dairy were consumed by the sample population in insufficient quantities.

Download Full-text

Treating irritable bowel syndrome with probiotics: the evidence

Proceedings of The Nutrition Society ◽

10.1017/s002966511000011x ◽

2010 ◽

Vol 69 (2) ◽

pp. 187-194 ◽

Cited By ~ 42

Author(s):

G. C. Parkes ◽

J. D. Sanderson ◽

K. Whelan

Keyword(s):

Irritable Bowel Syndrome ◽

Bacterial Overgrowth ◽

Abdominal Distension ◽

Small Intestinal Bacterial Overgrowth ◽

Bowel Habit ◽

Altered Bowel Habit ◽

Small Intestinal ◽

Irritable Bowel ◽

Developed World ◽

Post Infectious

Irritable bowel syndrome (IBS) is a disorder of chronic abdominal pain, altered bowel habit and abdominal distension. It is the commonest cause of referral to gastroenterologists in the developed world and yet current therapeutic strategies are often unsatisfactory. There is now increasing evidence linking alterations in the gastrointestinal (GI) microbiota and IBS. Changes in faecal and mucosa-associated microbiota, post-infectious IBS, a link with small intestinal bacterial overgrowth and an up-regulation of the GI mucosal immune system all suggest a role for the GI microbiota in the pathogenesis of IBS. Given this evidence, therapeutic alteration of the GI microbiota by probiotic bacteria could be beneficial. The present paper establishes an aetiological framework for the use of probiotics in IBS and comprehensively reviews randomised placebo-controlled trials of probiotics in IBS using multiple electronic databases. It highlights safety concerns over the use of probiotics and attempts to establish guidelines for their use in IBS in both primary and secondary care.

Download Full-text